Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Receivables (2016 - 2025)

Historic Receivables for Biomerica (BMRA) over the last 15 years, with Q4 2025 value amounting to $2.0 million.

  • Biomerica's Receivables fell 2571.86% to $2.0 million in Q4 2025 from the same period last year, while for Nov 2025 it was $2.0 million, marking a year-over-year decrease of 2571.86%. This contributed to the annual value of $1.5 million for FY2025, which is 2221.64% down from last year.
  • Biomerica's Receivables amounted to $2.0 million in Q4 2025, which was down 2571.86% from $2.5 million recorded in Q3 2025.
  • Biomerica's 5-year Receivables high stood at $3.7 million for Q2 2021, and its period low was $754559.0 during Q1 2023.
  • Moreover, its 5-year median value for Receivables was $1.9 million (2021), whereas its average is $1.9 million.
  • In the last 5 years, Biomerica's Receivables plummeted by 5460.43% in 2022 and then skyrocketed by 20988.78% in 2023.
  • Over the past 5 years, Biomerica's Receivables (Quarter) stood at $1.1 million in 2021, then fell by 24.46% to $850014.0 in 2022, then soared by 153.64% to $2.2 million in 2023, then increased by 24.26% to $2.7 million in 2024, then dropped by 25.72% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q4 2025, $2.5 million for Q3 2025, and $1.5 million during Q2 2025.